Health Care & Life Sciences » Pharmaceuticals | Tianjin Chase Sun Pharmaceutical Co. Ltd.

Tianjin Chase Sun Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Tianjin Chase Sun Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
E Fund Growth Enterprise Index ETF
7,652,103
0.33%
-826,100
0.65%
12/31/2017
Nanfang CSI 500 ETF
7,644,101
0.33%
-510,700
0.2%
12/31/2017
7,104,273
0.31%
-2,125,400
0.57%
12/31/2017
4,348,981
0.19%
-2,905,021
0.49%
12/31/2017
Soochow Jiahe Advantage Select Balanced Fund
3,596,400
0.16%
3,596,400
2.21%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
3,570,505
0.16%
0
0%
07/31/2018
3,223,500
0.14%
-574,100
0.8%
12/31/2017
1,750,000
0.08%
450,000
4.83%
12/31/2017
1,095,310
0.05%
-191,100
0.43%
12/31/2017
1,044,554
0.05%
-256,300
0.5%
12/31/2017

About Tianjin Chase Sun Pharmaceutical Co.

View Profile
Address
Quanfa West Road
Tianjin Tianjin 301700
China
Employees -
Website http://www.chasesun.cn
Updated 07/08/2019
Tianjin Chase Sun Pharmaceutical Co., Ltd. engages in the investment, manufacturing, and distribution of pharmaceuticals products. Its business includes Chinese herb preparation, Chinese medicinal granule, synthetic drugs, biotech drugs, medical apparatus, and therapies. The company was founded on September 23, 1996 and is headquartered in Tianjin, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.